AU2006326018B2 - Compositions and methods for dermally treating pain - Google Patents

Compositions and methods for dermally treating pain Download PDF

Info

Publication number
AU2006326018B2
AU2006326018B2 AU2006326018A AU2006326018A AU2006326018B2 AU 2006326018 B2 AU2006326018 B2 AU 2006326018B2 AU 2006326018 A AU2006326018 A AU 2006326018A AU 2006326018 A AU2006326018 A AU 2006326018A AU 2006326018 B2 AU2006326018 B2 AU 2006326018B2
Authority
AU
Australia
Prior art keywords
formulation
volatile solvent
pain
drug
solvent system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006326018A
Other languages
English (en)
Other versions
AU2006326018A1 (en
Inventor
Sanjay Sharma
Kevin S. Warner
Jie Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvo Research Inc
Original Assignee
Nuvo Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvo Research Inc filed Critical Nuvo Research Inc
Publication of AU2006326018A1 publication Critical patent/AU2006326018A1/en
Assigned to ZARS PHARMA, INC. reassignment ZARS PHARMA, INC. Request for Assignment Assignors: ZARS, INC.
Application granted granted Critical
Publication of AU2006326018B2 publication Critical patent/AU2006326018B2/en
Assigned to NUVO RESEARCH INC. reassignment NUVO RESEARCH INC. Request for Assignment Assignors: ZARS PHARMA, INC.
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2006326018A 2005-12-14 2006-12-14 Compositions and methods for dermally treating pain Ceased AU2006326018B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US75068305P 2005-12-14 2005-12-14
US75051905P 2005-12-14 2005-12-14
US75063705P 2005-12-14 2005-12-14
US60/750,637 2005-12-14
US60/750,519 2005-12-14
US60/750,683 2005-12-14
PCT/US2006/047926 WO2007070679A2 (en) 2005-12-14 2006-12-14 Compositions and methods for dermally treating pain

Publications (2)

Publication Number Publication Date
AU2006326018A1 AU2006326018A1 (en) 2007-06-21
AU2006326018B2 true AU2006326018B2 (en) 2013-04-18

Family

ID=38163542

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006326018A Ceased AU2006326018B2 (en) 2005-12-14 2006-12-14 Compositions and methods for dermally treating pain

Country Status (5)

Country Link
EP (1) EP1959931A4 (de)
JP (1) JP2009524586A (de)
AU (1) AU2006326018B2 (de)
CA (1) CA2633515C (de)
WO (1) WO2007070679A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
WO2008089242A1 (en) 2007-01-16 2008-07-24 Dermworx, Incorporated Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
US9283177B2 (en) * 2007-01-16 2016-03-15 Juventio, Llc Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
EP2252608A4 (de) 2008-02-29 2012-10-03 Vm Discovery Inc Verfahren zur behandlung von schmerzsysyndrom und anderen leiden
CA2730787A1 (en) * 2008-07-16 2010-01-21 David M. Cohen Topical drug delivery system
US9012477B2 (en) * 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
CA2757302A1 (en) * 2009-04-01 2010-10-07 Andrew Crockett Methods for treating myofascial, muscle, and/or back pain
WO2010129542A1 (en) 2009-05-04 2010-11-11 Jie Zhang Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
WO2011088333A2 (en) 2010-01-14 2011-07-21 Zars Pharma, Inc. Solid-forming local anesthetic formulations for pain control
EP2672956A1 (de) 2011-02-10 2013-12-18 Moberg Pharma AB Neue formulierungen für die dermale, transdermale und mukosale verwendung 1
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
BR122021017591B1 (pt) 2011-05-10 2022-05-10 Itochu Chemical Frontier Corporation Uso de lidocaína para a preparação de um curativo adesivo não-aquoso para o tratamento de dor
WO2012160125A1 (en) * 2011-05-26 2012-11-29 Novartis Ag Compositions for percutaneous administration of physiologically active agents
CN102302418B (zh) * 2011-09-21 2013-01-23 韩褆 节水型多功能洗手消毒液
CA2850024C (en) * 2011-09-27 2020-07-07 Itochu Chemical Frontier Corporation Non-aqueous patch comprising lidocaine
CN103142458B (zh) * 2013-01-22 2015-09-09 莱普德制药有限公司 无成瘾性镇痛缓释递药系统的组方与制备方法
GB201317718D0 (en) * 2013-10-07 2013-11-20 Buzzz Pharmaceuticals Ltd Novel formulation
JP6209749B2 (ja) * 2015-12-10 2017-10-11 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
US11141387B2 (en) 2017-01-05 2021-10-12 Medrx Co., Ltd. Memantine-containing transdermally absorbable liquid
WO2019112848A1 (en) 2017-12-04 2019-06-13 Johnson & Johnson Consumer Inc. Topical emulsion composition containing nonsteroidal anti-inflammatory drug
MX2023008983A (es) * 2021-02-02 2023-10-18 Dupont Nutrition Usa Inc Una composicion de gel acuoso que comprende una etilcelulosa.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001037890A1 (en) * 1999-11-23 2001-05-31 Ever Power Holding Inc A propellant free spray-on skin patch composition for improving wound healing and for drug administration
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US6562363B1 (en) * 1997-09-26 2003-05-13 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562363B1 (en) * 1997-09-26 2003-05-13 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
WO2001037890A1 (en) * 1999-11-23 2001-05-31 Ever Power Holding Inc A propellant free spray-on skin patch composition for improving wound healing and for drug administration
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces

Also Published As

Publication number Publication date
WO2007070679A3 (en) 2009-01-08
WO2007070679A2 (en) 2007-06-21
EP1959931A4 (de) 2012-08-22
JP2009524586A (ja) 2009-07-02
CA2633515C (en) 2011-10-18
CA2633515A1 (en) 2007-06-21
AU2006326018A1 (en) 2007-06-21
EP1959931A2 (de) 2008-08-27

Similar Documents

Publication Publication Date Title
AU2006326018B2 (en) Compositions and methods for dermally treating pain
US8741332B2 (en) Compositions and methods for dermally treating neuropathic pain
US20070189978A1 (en) Compositions and methods for dermally treating musculoskeletal pain
US8741333B2 (en) Compositions and methods for treating dermatitis or psoriasis
US20080019927A1 (en) Compositions and methods for dermally treating neuropathy with minoxidil
US20070190124A1 (en) Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
CA2633489C (en) Compositions and methods for treating dermatological conditions
US20070196453A1 (en) Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196452A1 (en) Flux-enabling compositions and methods for dermal delivery of drugs
US20070196457A1 (en) Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070189977A1 (en) Spray-on formulations and methods for dermal delivery of drugs
US20070196325A1 (en) Compositions and methods for dermally treating infections
CA2747845C (en) Compositions and methods for dermally treating pain
US20070196293A1 (en) Compositions and methods for treating photo damaged skin
US20070196323A1 (en) Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20070189980A1 (en) Compositions and methods for treating alopecia
US20070280972A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
CA2633472A1 (en) Flux-enabling compositions and methods for dermal delivery of drugs
WO2007070694A2 (en) Spray-on formulations and methods for dermal delivery of drugs
AU2006339350A1 (en) Compositions and methods for dermal delivery of drugs

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ZARS PHARMA, INC.

Free format text: FORMER APPLICANT(S): ZARS, INC.

PC1 Assignment before grant (sect. 113)

Owner name: NUVO RESEARCH INC.

Free format text: FORMER APPLICANT(S): ZARS PHARMA, INC.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired